TEM announces the acquisition of Deep 6 AI, enhancing its AI-driven clinical trial matching capabilities to accelerate patient recruitment and revolutionize precision medicine.

The excitement around reasoning models like OpenAI’s o1 and DeepSeek’s R1 got me thinking: How much are businesses actually ...

Cathie Wood’s ARK line of ETFs added more 29,845 Tempus AI (TEM) stock after the company announced the acquisition of Deep 6 AI ...

China-based DeepSeek shook up the world of generative artificial intelligence (GenAI) early this year with a low-cost but ...

Manus is making a splash right now similar to when DeepSeek debuted because it seems novel, unique, and powerful.

Chinese innovation isn’t stopping with DeepSeek. Late last week, a Wuhan-based tech company released an AI assistant named ...

Everyone in AI is talking about Manus. We put it to the test.

AI-driven healthcare solutions provider Tempus AI (TEM) has disclosed acquisition of Deep 6 AI, a precision research platform ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Remember the last time you visited a doctor? Behind the scenes, artificial intelligence might have played a crucial role in ...

Tempus AI traded as high as $65.03 and last traded at $66.61. Approximately 7,718,975 shares were traded during mid-day trading, a decline of 47% from the average daily volume of 14,686,510 shares ...

It’s been a rocky few days for Tempus AI (NASDAQ:TEM). After hitting a high of $91.45, the stock plummeted to a low of $55.20. All thanks to an earnings miss and news that CEO Jim Rogers sold ...